speb/financial-data huggingface dataset:
BMA.OL balance_sheet (quarterly, 2025-03-31) — Treasury Shares Number: 13920.00
BMA.OL balance_sheet (quarterly, 2025-03-31) — Treasury Stock: 0.00
BMA.OL balance_sheet (quarterly, 2025-03-31) — Working Capital: -242700000.00
BMA.OL income_statement (quarterly, 2025-06-30) — +Operating Expense: 262300000.00
BMA.OL income_statement (quarterly, 2025-06-30) — +Total Revenue: 6200000.00
BMA.OL balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 496000000.00
BMA.OL balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 412100000.00
BMA.OL balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 34600000.00
BMA.OL income_statement (quarterly, 2025-06-30) — Basic Average Shares: 69062500.00
BMA.OL income_statement (quarterly, 2025-06-30) — Basic EPS: 0.32
BMA.OL cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 35300000.00
BMA.OL cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -17000000.00
BMA.OL balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 306500000.00
BMA.OL balance_sheet (quarterly, 2025-06-30) — Capital Stock: 18200000.00
BMA.OL balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 27600000.00
BMA.OL balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 27600000.00
BMA.OL cash_flow (quarterly, 2025-06-30) — Changes In Cash: -7900000.00
BMA.OL balance_sheet (quarterly, 2025-06-30) — Common Stock: 18200000.00
BMA.OL balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 1034500000.00
BMA.OL income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 317700000.00
BMA.OL balance_sheet (quarterly, 2025-06-30) — Current Assets: 871700000.00
BMA.OL balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 20400000.00
BMA.OL balance_sheet (quarterly, 2025-06-30) — Current Debt: 597000000.00
BMA.OL balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 617400000.00
BMA.OL balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 1120900000.00
BMA.OL income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 22000000.00
BMA.OL income_statement (quarterly, 2025-06-30) — Depreciation Income Statement: 22000000.00
BMA.OL income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 69062500.00
BMA.OL income_statement (quarterly, 2025-06-30) — Diluted EPS: 0.32
BMA.OL income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 22100000.00
BMA.OL cash_flow (quarterly, 2025-06-30) — Dividends Received Cfi: 0.00
BMA.OL income_statement (quarterly, 2025-06-30) — EBIT: 48900000.00
BMA.OL income_statement (quarterly, 2025-06-30) — EBITDA: 70900000.00
BMA.OL cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: 200000.00
BMA.OL cash_flow (quarterly, 2025-06-30) — End Cash Position: 27600000.00
BMA.OL balance_sheet (quarterly, 2025-06-30) — Financial Assets: 13300000.00
BMA.OL cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: 10000000.00
BMA.OL cash_flow (quarterly, 2025-06-30) — Free Cash Flow: -18000000.00
BMA.OL balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 16400000.00
BMA.OL income_statement (quarterly, 2025-06-30) — Gross Profit: -311500000.00
BMA.OL balance_sheet (quarterly, 2025-06-30) — Hedging Assets Current: 15900000.00
BMA.OL income_statement (quarterly, 2025-06-30) — Interest Expense: 24800000.00
BMA.OL income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 24800000.00
BMA.OL cash_flow (quarterly, 2025-06-30) — Interest Paid Cfo: -30900000.00
BMA.OL cash_flow (quarterly, 2025-06-30) — Interest Received Cfo: 10500000.00
BMA.OL balance_sheet (quarterly, 2025-06-30) — Inventory: 416100000.00
BMA.OL balance_sheet (quarterly, 2025-06-30) — Invested Capital: 2195300000.00
BMA.OL cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -16900000.00
BMA.OL balance_sheet (quarterly, 2025-06-30) — Investment Properties: 157000000.00
BMA.OL balance_sheet (quarterly, 2025-06-30) — Investmentsin Associatesat Cost: 1259000000.00
BMA.OL cash_flow (quarterly, 2025-06-30) — Issuance Of Debt: -8800000.00
BMA.OL balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 286100000.00
BMA.OL balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 563800000.00
BMA.OL balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 849900000.00
BMA.OL cash_flow (quarterly, 2025-06-30) — Long Term Debt Issuance: -8800000.00
BMA.OL cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: -13500000.00
BMA.OL balance_sheet (quarterly, 2025-06-30) — Long Term Equity Investment: 1259000000.00
BMA.OL income_statement (quarterly, 2025-06-30) — Minority Interests: 0.00
BMA.OL cash_flow (quarterly, 2025-06-30) — Net Business Purchase And Sale: 0.00
BMA.OL balance_sheet (quarterly, 2025-06-30) — Net Debt: 1133200000.00
BMA.OL income_statement (quarterly, 2025-06-30) — Net Income: 22100000.00
BMA.OL income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 22100000.00
BMA.OL income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 22100000.00
BMA.OL income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 22100000.00
BMA.OL income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 22100000.00
BMA.OL income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 22100000.00
BMA.OL cash_flow (quarterly, 2025-06-30) — Net Intangibles Purchase And Sale: -200000.00
BMA.OL income_statement (quarterly, 2025-06-30) — Net Interest Income: -23300000.00
BMA.OL cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: 10000000.00
BMA.OL cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: -22300000.00
BMA.OL income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -23300000.00
BMA.OL balance_sheet (quarterly, 2025-06-30) — Net PPE: 792000000.00
BMA.OL cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -16800000.00
BMA.OL cash_flow (quarterly, 2025-06-30) — Net Short Term Debt Issuance: 32300000.00
BMA.OL balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 1018100000.00
BMA.OL balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Assets: 1700000.00
BMA.OL balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Liabilities: 106000000.00
BMA.OL income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 72400000.00
BMA.OL income_statement (quarterly, 2025-06-30) — Normalized Income: 23475518.67
BMA.OL cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: -1000000.00
BMA.OL income_statement (quarterly, 2025-06-30) — Operating Income: -573800000.00
BMA.OL income_statement (quarterly, 2025-06-30) — Operating Revenue: 6200000.00
BMA.OL balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 69819290.00
BMA.OL cash_flow (quarterly, 2025-06-30) — Other Cash Adjustment Outside Changein Cash: 0.00
BMA.OL balance_sheet (quarterly, 2025-06-30) — Other Equity Interest: 31600000.00
BMA.OL balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: -100000.00
BMA.OL income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 14000000.00
BMA.OL income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 89100000.00
BMA.OL income_statement (quarterly, 2025-06-30) — Otherunder Preferred Stock Dividend: 0.00
BMA.OL balance_sheet (quarterly, 2025-06-30) — Payables: 503500000.00
BMA.OL income_statement (quarterly, 2025-06-30) — Pretax Income: 24100000.00
BMA.OL cash_flow (quarterly, 2025-06-30) — Purchase Of Business: 0.00
BMA.OL cash_flow (quarterly, 2025-06-30) — Purchase Of Intangibles: -200000.00
BMA.OL cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -16800000.00
BMA.OL income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 317700000.00
BMA.OL income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 22000000.00
BMA.OL cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -13500000.00
BMA.OL balance_sheet (quarterly, 2025-06-30) — Retained Earnings: 950100000.00
BMA.OL cash_flow (quarterly, 2025-06-30) — Sale Of PPE: 0.00
BMA.OL income_statement (quarterly, 2025-06-30) — Selling And Marketing Expense: 17500000.00
BMA.OL income_statement (quarterly, 2025-06-30) — Selling General And Administration: 17500000.00
BMA.OL balance_sheet (quarterly, 2025-06-30) — Share Issued: 69819290.00
BMA.OL balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 1034500000.00
BMA.OL balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 1018100000.00
BMA.OL income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: -124481.33
BMA.OL income_statement (quarterly, 2025-06-30) — Tax Provision: 2000000.00
BMA.OL income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.08
BMA.OL cash_flow (quarterly, 2025-06-30) — Taxes Refund Paid: -600000.00
BMA.OL balance_sheet (quarterly, 2025-06-30) — Total Assets: 3111300000.00
BMA.OL balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 1598300000.00
BMA.OL balance_sheet (quarterly, 2025-06-30) — Total Debt: 1467300000.00
BMA.OL balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 1034500000.00
BMA.OL income_statement (quarterly, 2025-06-30) — Total Expenses: 580000000.00
BMA.OL balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 2076800000.00
BMA.OL balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 2239600000.00
BMA.OL balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 955900000.00
BMA.OL income_statement (quarterly, 2025-06-30) — Total Other Finance Cost: -1500000.00
BMA.OL balance_sheet (quarterly, 2025-06-30) — Total Tax Payable: 7500000.00
BMA.OL income_statement (quarterly, 2025-06-30) — Total Unusual Items: -1500000.00
BMA.OL income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: -1500000.00
BMA.OL balance_sheet (quarterly, 2025-06-30) — Treasury Stock: 0.00
BMA.OL balance_sheet (quarterly, 2025-06-30) — Working Capital: -249200000.00
BMA.OL income_statement (quarterly, 2025-09-30) — +Operating Expense: 206400000.00
BMA.OL income_statement (quarterly, 2025-09-30) — +Total Revenue: 537800000.00
BMA.OL balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 472400000.00
BMA.OL balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 383800000.00
BMA.OL balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 34600000.00
BMA.OL income_statement (quarterly, 2025-09-30) — Basic Average Shares: 69534884.00
BMA.OL income_statement (quarterly, 2025-09-30) — Basic EPS: 0.86
BMA.OL cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 27600000.00
BMA.OL cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -21300000.00
BMA.OL balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 301700000.00
BMA.OL balance_sheet (quarterly, 2025-09-30) — Capital Stock: 18200000.00
BMA.OL balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 28800000.00
BMA.OL balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 28800000.00
BMA.OL cash_flow (quarterly, 2025-09-30) — Changes In Cash: 1300000.00
BMA.OL balance_sheet (quarterly, 2025-09-30) — Common Stock: 18200000.00
BMA.OL balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 1083100000.00
BMA.OL income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 292200000.00
BMA.OL balance_sheet (quarterly, 2025-09-30) — Current Assets: 863800000.00
BMA.OL balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 19300000.00
BMA.OL balance_sheet (quarterly, 2025-09-30) — Current Debt: 610300000.00
BMA.OL balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 629600000.00
BMA.OL balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 1110600000.00
BMA.OL income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 22000000.00
BMA.OL income_statement (quarterly, 2025-09-30) — Depreciation Income Statement: 22000000.00
BMA.OL income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 69534884.00
BMA.OL income_statement (quarterly, 2025-09-30) — Diluted EPS: 0.86
BMA.OL income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 59800000.00
BMA.OL cash_flow (quarterly, 2025-09-30) — Dividends Received Cfi: 0.00
BMA.OL income_statement (quarterly, 2025-09-30) — EBIT: 91300000.00
BMA.OL income_statement (quarterly, 2025-09-30) — EBITDA: 113300000.00
BMA.OL cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: -100000.00
BMA.OL cash_flow (quarterly, 2025-09-30) — End Cash Position: 28800000.00
BMA.OL balance_sheet (quarterly, 2025-09-30) — Financial Assets: 23100000.00
BMA.OL cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -6500000.00
BMA.OL cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 7700000.00
BMA.OL balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 15400000.00
BMA.OL income_statement (quarterly, 2025-09-30) — Gross Profit: 245600000.00
BMA.OL balance_sheet (quarterly, 2025-09-30) — Hedging Assets Current: 23900000.00
BMA.OL income_statement (quarterly, 2025-09-30) — Interest Expense: 24400000.00
BMA.OL income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 24400000.00
BMA.OL cash_flow (quarterly, 2025-09-30) — Interest Paid Cfo: -23900000.00
BMA.OL cash_flow (quarterly, 2025-09-30) — Interest Received Cfo: 4600000.00
BMA.OL balance_sheet (quarterly, 2025-09-30) — Inventory: 427300000.00
BMA.OL balance_sheet (quarterly, 2025-09-30) — Invested Capital: 2242800000.00
BMA.OL cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -21200000.00
BMA.OL balance_sheet (quarterly, 2025-09-30) — Investment Properties: 157000000.00
BMA.OL balance_sheet (quarterly, 2025-09-30) — Investmentsin Associatesat Cost: 1283700000.00
BMA.OL cash_flow (quarterly, 2025-09-30) — Issuance Of Debt: -5300000.00
BMA.OL balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 282400000.00
BMA.OL balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 549400000.00
BMA.OL balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 831800000.00
BMA.OL cash_flow (quarterly, 2025-09-30) — Long Term Debt Issuance: -5300000.00
BMA.OL cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: -17400000.00
BMA.OL balance_sheet (quarterly, 2025-09-30) — Long Term Equity Investment: 1283700000.00
BMA.OL cash_flow (quarterly, 2025-09-30) — Net Business Purchase And Sale: 0.00
BMA.OL balance_sheet (quarterly, 2025-09-30) — Net Debt: 1130900000.00
BMA.OL income_statement (quarterly, 2025-09-30) — Net Income: 59800000.00
BMA.OL income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 59800000.00
BMA.OL income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 59800000.00
BMA.OL income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 59800000.00
BMA.OL income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 59800000.00
BMA.OL income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 59800000.00
BMA.OL cash_flow (quarterly, 2025-09-30) — Net Intangibles Purchase And Sale: -200000.00
BMA.OL income_statement (quarterly, 2025-09-30) — Net Interest Income: -25000000.00
BMA.OL cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: -6500000.00
BMA.OL cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: -22700000.00
BMA.OL income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -25000000.00
BMA.OL balance_sheet (quarterly, 2025-09-30) — Net PPE: 792900000.00
BMA.OL cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -21100000.00
BMA.OL cash_flow (quarterly, 2025-09-30) — Net Short Term Debt Issuance: 16200000.00
BMA.OL balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 1067700000.00
BMA.OL balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Assets: 1700000.00
BMA.OL balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 112000000.00
BMA.OL income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 111700000.00
BMA.OL income_statement (quarterly, 2025-09-30) — Normalized Income: 58369805.68
BMA.OL cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 29000000.00
BMA.OL income_statement (quarterly, 2025-09-30) — Operating Income: 39200000.00
BMA.OL income_statement (quarterly, 2025-09-30) — Operating Revenue: 537800000.00
BMA.OL balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 69819290.00
BMA.OL cash_flow (quarterly, 2025-09-30) — Other Cash Adjustment Outside Changein Cash: 0.00
BMA.OL balance_sheet (quarterly, 2025-09-30) — Other Equity Interest: 23400000.00
BMA.OL balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: -200000.00
BMA.OL balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 100000.00
BMA.OL income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 18100000.00
BMA.OL income_statement (quarterly, 2025-09-30) — Other Operating Expenses: 73800000.00
BMA.OL income_statement (quarterly, 2025-09-30) — Otherunder Preferred Stock Dividend: 0.00
BMA.OL balance_sheet (quarterly, 2025-09-30) — Payables: 481000000.00
BMA.OL income_statement (quarterly, 2025-09-30) — Pretax Income: 66900000.00
BMA.OL cash_flow (quarterly, 2025-09-30) — Purchase Of Business: 0.00
BMA.OL cash_flow (quarterly, 2025-09-30) — Purchase Of Intangibles: -200000.00
BMA.OL cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -21100000.00
BMA.OL income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 292200000.00
BMA.OL income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 22000000.00
BMA.OL cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -17400000.00
BMA.OL balance_sheet (quarterly, 2025-09-30) — Retained Earnings: 1006900000.00
BMA.OL cash_flow (quarterly, 2025-09-30) — Sale Of PPE: 0.00
BMA.OL income_statement (quarterly, 2025-09-30) — Selling And Marketing Expense: 18800000.00
BMA.OL income_statement (quarterly, 2025-09-30) — Selling General And Administration: 18800000.00
BMA.OL balance_sheet (quarterly, 2025-09-30) — Share Issued: 69833210.00
BMA.OL balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 1083100000.00
BMA.OL balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 1067700000.00
BMA.OL income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 169805.68
BMA.OL income_statement (quarterly, 2025-09-30) — Tax Provision: 7100000.00
BMA.OL income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.11
BMA.OL cash_flow (quarterly, 2025-09-30) — Taxes Refund Paid: 1200000.00
BMA.OL balance_sheet (quarterly, 2025-09-30) — Total Assets: 3137600000.00
BMA.OL balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 1632500000.00
BMA.OL balance_sheet (quarterly, 2025-09-30) — Total Debt: 1461400000.00
BMA.OL balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 1083100000.00
BMA.OL income_statement (quarterly, 2025-09-30) — Total Expenses: 498600000.00
BMA.OL balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 2054500000.00
BMA.OL balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 2273900000.00
BMA.OL balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 943900000.00
BMA.OL income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: 57200000.00
BMA.OL income_statement (quarterly, 2025-09-30) — Total Other Finance Cost: 600000.00
BMA.OL balance_sheet (quarterly, 2025-09-30) — Total Tax Payable: 8600000.00
BMA.OL income_statement (quarterly, 2025-09-30) — Total Unusual Items: 1600000.00
BMA.OL income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: 1600000.00
BMA.OL balance_sheet (quarterly, 2025-09-30) — Treasury Shares Number: 13920.00
BMA.OL balance_sheet (quarterly, 2025-09-30) — Treasury Stock: 0.00
BMA.OL balance_sheet (quarterly, 2025-09-30) — Working Capital: -246800000.00
BMA.OL income_statement (annual, 2025-12-31) — +Operating Expense: 1071107000.00
BMA.OL income_statement (quarterly, 2025-12-31) — +Operating Expense: 346700000.00
BMA.OL income_statement (annual, 2025-12-31) — +Total Revenue: 2355806000.00
BMA.OL income_statement (quarterly, 2025-12-31) — +Total Revenue: 589700000.00
BMA.OL balance_sheet (annual, 2025-12-31) — Accounts Payable: 297790000.00
BMA.OL balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 297790000.00
BMA.OL balance_sheet (annual, 2025-12-31) — Accounts Receivable: 205359000.00
BMA.OL balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 205359000.00
BMA.OL balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -1287386000.00
BMA.OL balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -1287386000.00
BMA.OL balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 34499000.00
BMA.OL balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 34499000.00
BMA.OL income_statement (annual, 2025-12-31) — Amortization: 4248000.00
BMA.OL cash_flow (annual, 2025-12-31) — Amortization Cash Flow: 4248000.00
BMA.OL income_statement (annual, 2025-12-31) — Basic Average Shares: 69819000.00
BMA.OL income_statement (quarterly, 2025-12-31) — Basic Average Shares: 70107527.00
BMA.OL income_statement (annual, 2025-12-31) — Basic EPS: 1.55
BMA.OL income_statement (quarterly, 2025-12-31) — Basic EPS: -0.93
BMA.OL cash_flow (annual, 2025-12-31) — Beginning Cash Position: 51416000.00
BMA.OL cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 28800000.00
BMA.OL balance_sheet (annual, 2025-12-31) — Buildings And Improvements: 550787000.00
BMA.OL balance_sheet (quarterly, 2025-12-31) — Buildings And Improvements: 550787000.00
BMA.OL cash_flow (annual, 2025-12-31) — Capital Expenditure: -88242000.00
BMA.OL cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -29342000.00
BMA.OL balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 62515000.00
BMA.OL balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 62515000.00
BMA.OL balance_sheet (annual, 2025-12-31) — Capital Stock: 18157000.00
BMA.OL balance_sheet (quarterly, 2025-12-31) — Capital Stock: 18157000.00
BMA.OL balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 19832000.00
BMA.OL balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 19832000.00
BMA.OL balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 19832000.00
BMA.OL balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 19832000.00
BMA.OL balance_sheet (annual, 2025-12-31) — Cash Financial: 19832000.00
BMA.OL balance_sheet (quarterly, 2025-12-31) — Cash Financial: 19832000.00
BMA.OL cash_flow (annual, 2025-12-31) — Change In Inventory: -48168000.00
BMA.OL cash_flow (annual, 2025-12-31) — Change In Payable: 16713000.00
BMA.OL cash_flow (annual, 2025-12-31) — Change In Receivables: 154476000.00
BMA.OL cash_flow (annual, 2025-12-31) — Change In Working Capital: 123021000.00
BMA.OL cash_flow (annual, 2025-12-31) — Changes In Cash: -15955000.00
BMA.OL cash_flow (quarterly, 2025-12-31) — Changes In Cash: 7045000.00
BMA.OL balance_sheet (annual, 2025-12-31) — Common Stock: 18157000.00
BMA.OL balance_sheet (quarterly, 2025-12-31) — Common Stock: 18157000.00
BMA.OL balance_sheet (annual, 2025-12-31) — Common Stock Equity: 1023456000.00
BMA.OL balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 1023456000.00
BMA.OL balance_sheet (annual, 2025-12-31) — Construction In Progress: 71808000.00
BMA.OL balance_sheet (quarterly, 2025-12-31) — Construction In Progress: 71808000.00
BMA.OL income_statement (annual, 2025-12-31) — Cost Of Revenue: 1188726000.00
BMA.OL income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 233400000.00
BMA.OL balance_sheet (annual, 2025-12-31) — Current Assets: 649215000.00
BMA.OL balance_sheet (quarterly, 2025-12-31) — Current Assets: 649215000.00
BMA.OL balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 18035000.00
BMA.OL balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 18035000.00
BMA.OL balance_sheet (annual, 2025-12-31) — Current Debt: 443567000.00
BMA.OL balance_sheet (quarterly, 2025-12-31) — Current Debt: 443567000.00
BMA.OL balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 461602000.00
BMA.OL balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 461602000.00
BMA.OL balance_sheet (annual, 2025-12-31) — Current Liabilities: 957853000.00
BMA.OL balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 957853000.00
BMA.OL balance_sheet (annual, 2025-12-31) — Current Provisions: 2330000.00
BMA.OL balance_sheet (quarterly, 2025-12-31) — Current Provisions: 2330000.00
BMA.OL cash_flow (annual, 2025-12-31) — Deferred Tax: 8992000.00
BMA.OL cash_flow (annual, 2025-12-31) — Depreciation: 82430000.00
BMA.OL cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 86678000.00
BMA.OL income_statement (annual, 2025-12-31) — Depreciation And Amortization In Income Statement: 86678000.00
BMA.OL income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 20700000.00
BMA.OL income_statement (annual, 2025-12-31) — Depreciation Income Statement: 82430000.00
BMA.OL income_statement (quarterly, 2025-12-31) — Depreciation Income Statement: 20700000.00
BMA.OL balance_sheet (annual, 2025-12-31) — Derivative Product Liabilities: 0.00
BMA.OL balance_sheet (quarterly, 2025-12-31) — Derivative Product Liabilities: 0.00
BMA.OL income_statement (annual, 2025-12-31) — Diluted Average Shares: 69819000.00
BMA.OL income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 70107527.00
BMA.OL income_statement (annual, 2025-12-31) — Diluted EPS: 1.55
BMA.OL income_statement (quarterly, 2025-12-31) — Diluted EPS: -0.93
BMA.OL income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 108279000.00
BMA.OL income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -65200000.00
BMA.OL cash_flow (annual, 2025-12-31) — Dividends Received Cfi: 0.00
BMA.OL cash_flow (quarterly, 2025-12-31) — Dividends Received Cfi: 0.00
BMA.OL income_statement (annual, 2025-12-31) — EBIT: 213132000.00
BMA.OL income_statement (quarterly, 2025-12-31) — EBIT: -48100000.00
BMA.OL income_statement (annual, 2025-12-31) — EBITDA: 299810000.00
BMA.OL income_statement (quarterly, 2025-12-31) — EBITDA: -27400000.00
BMA.OL cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: 946000.00
BMA.OL cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: 646000.00
BMA.OL cash_flow (annual, 2025-12-31) — End Cash Position: 36407000.00
BMA.OL cash_flow (quarterly, 2025-12-31) — End Cash Position: 36407000.00
BMA.OL balance_sheet (annual, 2025-12-31) — Financial Assets: 17043000.00
BMA.OL balance_sheet (quarterly, 2025-12-31) — Financial Assets: 17043000.00
BMA.OL cash_flow (annual, 2025-12-31) — Financing Cash Flow: -171567000.00
BMA.OL cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -188567000.00
BMA.OL balance_sheet (annual, 2025-12-31) — Finished Goods: 223134000.00
BMA.OL balance_sheet (quarterly, 2025-12-31) — Finished Goods: 223134000.00
BMA.OL cash_flow (annual, 2025-12-31) — Free Cash Flow: 156007000.00
BMA.OL cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 196107000.00
BMA.OL cash_flow (annual, 2025-12-31) — Gain Loss On Investment Securities: -3932000.00
BMA.OL cash_flow (annual, 2025-12-31) — Gain Loss On Sale Of PPE: -315000.00
BMA.OL income_statement (annual, 2025-12-31) — General And Administrative Expense: 28025000.00
BMA.OL balance_sheet (annual, 2025-12-31) — Goodwill: 6966000.00
BMA.OL balance_sheet (quarterly, 2025-12-31) — Goodwill: 6966000.00
BMA.OL balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 15161000.00
BMA.OL balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 15161000.00
BMA.OL balance_sheet (annual, 2025-12-31) — Gross PPE: 2112671000.00
BMA.OL balance_sheet (quarterly, 2025-12-31) — Gross PPE: 2112671000.00
BMA.OL income_statement (annual, 2025-12-31) — Gross Profit: 1167080000.00
BMA.OL income_statement (quarterly, 2025-12-31) — Gross Profit: 356300000.00
BMA.OL balance_sheet (annual, 2025-12-31) — Hedging Assets Current: 14497000.00
BMA.OL balance_sheet (quarterly, 2025-12-31) — Hedging Assets Current: 14497000.00
BMA.OL income_statement (annual, 2025-12-31) — Interest Expense: 95861000.00
BMA.OL income_statement (quarterly, 2025-12-31) — Interest Expense: 20800000.00
BMA.OL income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 95861000.00
BMA.OL income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 20800000.00
BMA.OL income_statement (annual, 2025-12-31) — Interest Income: 1340000.00
BMA.OL income_statement (annual, 2025-12-31) — Interest Income Non Operating: 1340000.00
BMA.OL cash_flow (annual, 2025-12-31) — Interest Paid Cfo: -80312000.00
BMA.OL cash_flow (quarterly, 2025-12-31) — Interest Paid Cfo: -7212000.00
BMA.OL cash_flow (annual, 2025-12-31) — Interest Received Cfo: 1340000.00
BMA.OL cash_flow (quarterly, 2025-12-31) — Interest Received Cfo: -13860000.00
BMA.OL balance_sheet (annual, 2025-12-31) — Inventory: 392951000.00
BMA.OL balance_sheet (quarterly, 2025-12-31) — Inventory: 392951000.00
BMA.OL balance_sheet (annual, 2025-12-31) — Invested Capital: 2251127000.00
BMA.OL balance_sheet (quarterly, 2025-12-31) — Invested Capital: 2251127000.00
BMA.OL cash_flow (annual, 2025-12-31) — Investing Cash Flow: -88637000.00
BMA.OL cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -29837000.00
BMA.OL balance_sheet (annual, 2025-12-31) — Investment Properties: 161500000.00
BMA.OL balance_sheet (quarterly, 2025-12-31) — Investment Properties: 161500000.00
BMA.OL balance_sheet (annual, 2025-12-31) — Investmentsin Associatesat Cost: 1247046000.00
BMA.OL balance_sheet (quarterly, 2025-12-31) — Investmentsin Associatesat Cost: 1247046000.00
BMA.OL cash_flow (annual, 2025-12-31) — Issuance Of Debt: 6259000.00
BMA.OL cash_flow (quarterly, 2025-12-31) — Issuance Of Debt: -41000.00
BMA.OL balance_sheet (annual, 2025-12-31) — Land And Improvements: 75226000.00
BMA.OL balance_sheet (quarterly, 2025-12-31) — Land And Improvements: 75226000.00
BMA.OL balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 44480000.00
BMA.OL balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 44480000.00
BMA.OL balance_sheet (annual, 2025-12-31) — Long Term Debt: 784104000.00
BMA.OL balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 784104000.00
BMA.OL balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 828584000.00
BMA.OL balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 828584000.00
BMA.OL cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 6259000.00
BMA.OL cash_flow (quarterly, 2025-12-31) — Long Term Debt Issuance: -41000.00
BMA.OL cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -81442000.00
BMA.OL cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: -36742000.00
BMA.OL balance_sheet (annual, 2025-12-31) — Long Term Equity Investment: 1247046000.00
BMA.OL balance_sheet (quarterly, 2025-12-31) — Long Term Equity Investment: 1247046000.00
BMA.OL balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 1414849000.00
BMA.OL balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 1414849000.00
BMA.OL cash_flow (annual, 2025-12-31) — Net Business Purchase And Sale: 0.00
BMA.OL cash_flow (quarterly, 2025-12-31) — Net Business Purchase And Sale: 0.00
BMA.OL balance_sheet (annual, 2025-12-31) — Net Debt: 1207839000.00
BMA.OL balance_sheet (quarterly, 2025-12-31) — Net Debt: 1207839000.00
BMA.OL income_statement (annual, 2025-12-31) — Net Income: 108279000.00
BMA.OL income_statement (quarterly, 2025-12-31) — Net Income: -65200000.00
BMA.OL income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 108279000.00
BMA.OL income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -65200000.00
BMA.OL income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 108279000.00
BMA.OL income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -65200000.00
BMA.OL income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 108279000.00
BMA.OL income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -65200000.00
BMA.OL income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 108279000.00
BMA.OL income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -65200000.00
BMA.OL cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 108279000.00
BMA.OL income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 108279000.00
BMA.OL income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -65200000.00
BMA.OL cash_flow (annual, 2025-12-31) — Net Intangibles Purchase And Sale: -1021000.00
BMA.OL cash_flow (quarterly, 2025-12-31) — Net Intangibles Purchase And Sale: -321000.00
BMA.OL income_statement (annual, 2025-12-31) — Net Interest Income: -97011000.00
BMA.OL income_statement (quarterly, 2025-12-31) — Net Interest Income: -23500000.00
BMA.OL cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: -171567000.00
BMA.OL cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: -188567000.00
BMA.OL cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: -75183000.00
BMA.OL cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: -36783000.00
BMA.OL income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -97011000.00
BMA.OL income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -23500000.00
BMA.OL cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -100000.00
BMA.OL balance_sheet (annual, 2025-12-31) — Net PPE: 825284000.00
BMA.OL balance_sheet (quarterly, 2025-12-31) — Net PPE: 825284000.00
BMA.OL cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -86906000.00
BMA.OL cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -28706000.00
BMA.OL cash_flow (annual, 2025-12-31) — Net Short Term Debt Issuance: -96384000.00
BMA.OL cash_flow (quarterly, 2025-12-31) — Net Short Term Debt Issuance: -151784000.00
BMA.OL balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 1008295000.00
BMA.OL balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 1008295000.00
BMA.OL balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Assets: 1270000.00
BMA.OL balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Assets: 1270000.00
BMA.OL balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Liabilities: 106723000.00
BMA.OL balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Liabilities: 106723000.00
BMA.OL income_statement (annual, 2025-12-31) — Normalized EBITDA: 299074000.00
BMA.OL income_statement (quarterly, 2025-12-31) — Normalized EBITDA: -22900000.00
BMA.OL income_statement (annual, 2025-12-31) — Normalized Income: 107599434.34
BMA.OL income_statement (quarterly, 2025-12-31) — Normalized Income: -60948185.78
BMA.OL cash_flow (annual, 2025-12-31) — Operating Cash Flow: 244249000.00
BMA.OL cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 225449000.00
BMA.OL income_statement (annual, 2025-12-31) — Operating Income: 95973000.00
BMA.OL income_statement (quarterly, 2025-12-31) — Operating Income: 9600000.00
BMA.OL income_statement (annual, 2025-12-31) — Operating Revenue: 2355806000.00
BMA.OL income_statement (quarterly, 2025-12-31) — Operating Revenue: 589700000.00
BMA.OL balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 69819290.00
BMA.OL balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 69819290.00
BMA.OL balance_sheet (annual, 2025-12-31) — Other Equity Interest: 28681000.00
BMA.OL balance_sheet (quarterly, 2025-12-31) — Other Equity Interest: 28681000.00
BMA.OL balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 8195000.00
BMA.OL balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 8195000.00
BMA.OL balance_sheet (annual, 2025-12-31) — Other Inventories: -1000.00
BMA.OL balance_sheet (quarterly, 2025-12-31) — Other Inventories: -1000.00
BMA.OL cash_flow (annual, 2025-12-31) — Other Non Cash Items: 89759000.00
BMA.OL balance_sheet (annual, 2025-12-31) — Other Non Current Liabilities: -100000.00
BMA.OL balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: -100000.00
BMA.OL income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: 29783000.00
BMA.OL income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: -6600000.00
BMA.OL income_statement (annual, 2025-12-31) — Other Operating Expenses: 309694000.00
BMA.OL income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 88100000.00
BMA.OL balance_sheet (annual, 2025-12-31) — Other Properties: 1000.00
BMA.OL balance_sheet (quarterly, 2025-12-31) — Other Properties: 1000.00
BMA.OL income_statement (annual, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00
BMA.OL income_statement (quarterly, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00
BMA.OL balance_sheet (annual, 2025-12-31) — Payables: 362519000.00
BMA.OL balance_sheet (quarterly, 2025-12-31) — Payables: 362519000.00
BMA.OL income_statement (annual, 2025-12-31) — Pretax Income: 117271000.00
BMA.OL income_statement (quarterly, 2025-12-31) — Pretax Income: -68900000.00
BMA.OL balance_sheet (annual, 2025-12-31) — Properties: 0.00
BMA.OL balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
BMA.OL cash_flow (annual, 2025-12-31) — Purchase Of Business: 0.00
BMA.OL cash_flow (quarterly, 2025-12-31) — Purchase Of Business: 0.00
BMA.OL cash_flow (annual, 2025-12-31) — Purchase Of Intangibles: -1021000.00
BMA.OL cash_flow (quarterly, 2025-12-31) — Purchase Of Intangibles: -321000.00
BMA.OL cash_flow (annual, 2025-12-31) — Purchase Of PPE: -87221000.00
BMA.OL cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -29021000.00
BMA.OL balance_sheet (annual, 2025-12-31) — Raw Materials: 136021000.00
BMA.OL balance_sheet (quarterly, 2025-12-31) — Raw Materials: 136021000.00
BMA.OL income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 1188726000.00
BMA.OL income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 233400000.00
BMA.OL income_statement (annual, 2025-12-31) — Reconciled Depreciation: 86678000.00
BMA.OL income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 20700000.00
BMA.OL income_statement (annual, 2025-12-31) — Rent And Landing Fees: 39028000.00
BMA.OL income_statement (annual, 2025-12-31) — Rent Expense Supplemental: 39028000.00
BMA.OL cash_flow (annual, 2025-12-31) — Repayment Of Debt: -81442000.00
BMA.OL cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -36742000.00
BMA.OL balance_sheet (annual, 2025-12-31) — Restricted Cash: 16576000.00
BMA.OL balance_sheet (quarterly, 2025-12-31) — Restricted Cash: 16576000.00
BMA.OL balance_sheet (annual, 2025-12-31) — Retained Earnings: 942123000.00
BMA.OL balance_sheet (quarterly, 2025-12-31) — Retained Earnings: 942123000.00
BMA.OL cash_flow (annual, 2025-12-31) — Sale Of PPE: 315000.00
BMA.OL cash_flow (quarterly, 2025-12-31) — Sale Of PPE: 315000.00
BMA.OL income_statement (annual, 2025-12-31) — Selling And Marketing Expense: 103690000.00
BMA.OL income_statement (quarterly, 2025-12-31) — Selling And Marketing Expense: 93000000.00
BMA.OL income_statement (annual, 2025-12-31) — Selling General And Administration: 131715000.00
BMA.OL income_statement (quarterly, 2025-12-31) — Selling General And Administration: 93000000.00
BMA.OL balance_sheet (annual, 2025-12-31) — Share Issued: 69833210.00
BMA.OL balance_sheet (quarterly, 2025-12-31) — Share Issued: 69833210.00
BMA.OL balance_sheet (annual, 2025-12-31) — Stockholders Equity: 1023456000.00
BMA.OL balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 1023456000.00
BMA.OL balance_sheet (annual, 2025-12-31) — Tangible Book Value: 1008295000.00
BMA.OL balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 1008295000.00
BMA.OL income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 56434.34
BMA.OL income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: -248185.78
BMA.OL income_statement (annual, 2025-12-31) — Tax Provision: 8992000.00
BMA.OL income_statement (quarterly, 2025-12-31) — Tax Provision: -3800000.00
BMA.OL income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.08
BMA.OL income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.06
BMA.OL cash_flow (annual, 2025-12-31) — Taxes Refund Paid: -5971000.00
BMA.OL cash_flow (quarterly, 2025-12-31) — Taxes Refund Paid: -671000.00
BMA.OL balance_sheet (annual, 2025-12-31) — Total Assets: 2916616000.00
BMA.OL balance_sheet (quarterly, 2025-12-31) — Total Assets: 2916616000.00
BMA.OL balance_sheet (annual, 2025-12-31) — Total Capitalization: 1807560000.00
BMA.OL balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 1807560000.00
BMA.OL balance_sheet (annual, 2025-12-31) — Total Debt: 1290186000.00
BMA.OL balance_sheet (quarterly, 2025-12-31) — Total Debt: 1290186000.00
BMA.OL balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 1023456000.00
BMA.OL balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 1023456000.00
BMA.OL income_statement (annual, 2025-12-31) — Total Expenses: 2259833000.00
BMA.OL income_statement (quarterly, 2025-12-31) — Total Expenses: 580100000.00
BMA.OL balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 1893160000.00
BMA.OL balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 1893160000.00
BMA.OL balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 2267401000.00
BMA.OL balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 2267401000.00
BMA.OL balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 935307000.00
BMA.OL balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 935307000.00
BMA.OL income_statement (annual, 2025-12-31) — Total Operating Income As Reported: 130258000.00
BMA.OL income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: 2800000.00
BMA.OL income_statement (annual, 2025-12-31) — Total Other Finance Cost: 2490000.00
BMA.OL income_statement (quarterly, 2025-12-31) — Total Other Finance Cost: 2700000.00
BMA.OL balance_sheet (annual, 2025-12-31) — Total Tax Payable: 64729000.00
BMA.OL balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 64729000.00
BMA.OL income_statement (annual, 2025-12-31) — Total Unusual Items: 736000.00
BMA.OL income_statement (quarterly, 2025-12-31) — Total Unusual Items: -4500000.00
BMA.OL income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: 736000.00
BMA.OL income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: -4500000.00
BMA.OL balance_sheet (annual, 2025-12-31) — Treasury Shares Number: 13920.00
BMA.OL balance_sheet (quarterly, 2025-12-31) — Treasury Shares Number: 13920.00
BMA.OL balance_sheet (annual, 2025-12-31) — Treasury Stock: 4000.00
BMA.OL balance_sheet (quarterly, 2025-12-31) — Treasury Stock: 4000.00
BMA.OL balance_sheet (annual, 2025-12-31) — Work In Process: 33797000.00
BMA.OL balance_sheet (quarterly, 2025-12-31) — Work In Process: 33797000.00
BMA.OL balance_sheet (annual, 2025-12-31) — Working Capital: -308638000.00
BMA.OL balance_sheet (quarterly, 2025-12-31) — Working Capital: -308638000.00
BMA.OL income_statement (quarterly, 2026-03-31) — +Operating Expense: 264000000.00
BMA.OL income_statement (quarterly, 2026-03-31) — +Total Revenue: 652500000.00
BMA.OL balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 504500000.00
BMA.OL balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 246000000.00
BMA.OL balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 34600000.00
BMA.OL income_statement (quarterly, 2026-03-31) — Basic Average Shares: 70000000.00
BMA.OL income_statement (quarterly, 2026-03-31) — Basic EPS: 1.64
BMA.OL cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 36400000.00
BMA.OL cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -16100000.00
BMA.OL balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 287500000.00
BMA.OL balance_sheet (quarterly, 2026-03-31) — Capital Stock: 18200000.00
BMA.OL balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 14700000.00
BMA.OL balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 14700000.00
BMA.OL cash_flow (quarterly, 2026-03-31) — Changes In Cash: -20700000.00
BMA.OL balance_sheet (quarterly, 2026-03-31) — Common Stock: 18200000.00
BMA.OL balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 1093300000.00
BMA.OL income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 350400000.00
BMA.OL balance_sheet (quarterly, 2026-03-31) — Current Assets: 675900000.00
BMA.OL balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 16800000.00
BMA.OL balance_sheet (quarterly, 2026-03-31) — Current Debt: 418000000.00
BMA.OL balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 434800000.00
BMA.OL balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 943700000.00
BMA.OL income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 21800000.00
BMA.OL income_statement (quarterly, 2026-03-31) — Depreciation Income Statement: 21800000.00
BMA.OL income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 70000000.00
BMA.OL income_statement (quarterly, 2026-03-31) — Diluted EPS: 1.64
BMA.OL income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 114800000.00
BMA.OL cash_flow (quarterly, 2026-03-31) — Dividends Received Cfi: 0.00
BMA.OL income_statement (quarterly, 2026-03-31) — EBIT: 148900000.00
BMA.OL income_statement (quarterly, 2026-03-31) — EBITDA: 170700000.00
BMA.OL cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: -1000000.00
BMA.OL cash_flow (quarterly, 2026-03-31) — End Cash Position: 14700000.00
BMA.OL balance_sheet (quarterly, 2026-03-31) — Financial Assets: 13700000.00
BMA.OL cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -41900000.00
BMA.OL cash_flow (quarterly, 2026-03-31) — Free Cash Flow: 20700000.00
BMA.OL balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 14400000.00
BMA.OL income_statement (quarterly, 2026-03-31) — Gross Profit: 302100000.00
BMA.OL balance_sheet (quarterly, 2026-03-31) — Hedging Assets Current: 44700000.00
BMA.OL income_statement (quarterly, 2026-03-31) — Interest Expense: 20700000.00
BMA.OL income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 20700000.00
BMA.OL cash_flow (quarterly, 2026-03-31) — Interest Paid Cfo: -17100000.00
BMA.OL cash_flow (quarterly, 2026-03-31) — Interest Received Cfo: 100000.00
BMA.OL balance_sheet (quarterly, 2026-03-31) — Inventory: 370500000.00
BMA.OL balance_sheet (quarterly, 2026-03-31) — Invested Capital: 2042400000.00
BMA.OL cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -15600000.00
BMA.OL balance_sheet (quarterly, 2026-03-31) — Investment Properties: 161500000.00
BMA.OL balance_sheet (quarterly, 2026-03-31) — Investmentsin Associatesat Cost: 1269100000.00
BMA.OL cash_flow (quarterly, 2026-03-31) — Issuance Of Debt: 2000000.00
BMA.OL balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 270700000.00
BMA.OL balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 531100000.00
BMA.OL balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 801800000.00
BMA.OL cash_flow (quarterly, 2026-03-31) — Long Term Debt Issuance: 2000000.00
BMA.OL cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -21600000.00
BMA.OL balance_sheet (quarterly, 2026-03-31) — Long Term Equity Investment: 1269100000.00
BMA.OL cash_flow (quarterly, 2026-03-31) — Net Business Purchase And Sale: 0.00
BMA.OL balance_sheet (quarterly, 2026-03-31) — Net Debt: 934400000.00
BMA.OL income_statement (quarterly, 2026-03-31) — Net Income: 114800000.00